INOZYME PHARMA, INC. Earnings Per Share (Diluted)
INOZYME PHARMA, INC. reported Earnings Per Share (Diluted) of -$0.44 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-05-14
- INOZYME PHARMA, INC. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.44.
- INOZYME PHARMA, INC. earnings per share, diluted for the quarter ending 2024-12-31 was -$0.42.
- INOZYME PHARMA, INC. earnings per share, diluted for the quarter ending 2024-09-30 was -$0.39.
- INOZYME PHARMA, INC. earnings per share, diluted for the quarter ending 2024-06-30 was -$0.44.
- INOZYME PHARMA, INC. earnings per share, diluted for fiscal 2024 was -$1.62.
- INOZYME PHARMA, INC. earnings per share, diluted for fiscal 2023 was -$1.37.
- INOZYME PHARMA, INC. earnings per share, diluted for fiscal 2022 was -$1.78.
- INOZYME PHARMA, INC. earnings per share, diluted for fiscal 2021 was -$2.40.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$0.44 10-Q · filed 2025-05-14 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.68 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2024-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$1.25 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$1.62 10-K · filed 2025-03-10 |
| 2024-09-30 | -$0.39 10-Q · filed 2024-11-05 | -$0.82 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$1.20 10-Q · filed 2024-11-05 | -$1.55 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2024-06-30 | -$0.44 10-Q · filed 2024-08-06 | -$0.81 10-Q · filed 2024-08-06 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.46 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2024-03-31 | -$0.38 10-Q · filed 2025-05-14 | -$0.73 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-05-14 |
| 2023-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$0.99 derived: net income ÷ weighted average shares · filed 2025-03-10 | -$1.37 10-K · filed 2025-03-10 |
| 2023-09-30 | -$0.29 10-Q · filed 2024-11-05 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$1.02 10-Q · filed 2024-11-05 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-11-05 |
| 2023-06-30 | -$0.35 10-Q · filed 2024-08-06 | -$0.74 10-Q · filed 2024-08-06 | -$1.17 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-11-05 |
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-07 | -$0.82 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$1.58 derived: net income ÷ weighted average shares · filed 2024-11-05 |
| 2022-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$1.18 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$1.78 10-K · filed 2024-03-12 |
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-07 | -$0.76 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.36 10-Q · filed 2023-11-07 | -$2.06 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-06-30 | -$0.38 10-Q · filed 2023-08-08 | -$1.01 10-Q · filed 2023-08-08 | -$1.75 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.36 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-03-31 | -$0.71 10-Q · filed 2023-05-09 | -$1.51 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.11 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.64 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2021-12-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$2.40 10-K · filed 2023-03-22 |
| 2021-09-30 | -$0.60 10-Q · filed 2022-11-10 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.61 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$0.53 10-Q · filed 2022-08-15 | -$1.01 10-Q · filed 2022-08-15 |